Suchergebnisse - Rune Viig Overgaard

Efficacy, Safety and PK of Once‐Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model‐Informed Drug... von Rune Viig Overgaard, Oscar Birkhan, Naveen Rathor, Thomas Sparsø, Anders Strathe, Sean Wharton, Domenica Rubino

Volltext

Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model‐Informed Drug Development Approach von Anders Strathe, Eric M. Bomberg, Garrit Jensch, Jonas Kildegaard, Nina M. Harder‐Lauridsen, Daniel Weghuber, Rune Viig Overgaard

Volltext